Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development

被引:34
作者
Sakashita, K
Koike, K
Kinoshita, T
Shiohara, M
Kamijo, T
Taniguchi, S
Kubota, T
机构
[1] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan
[3] Shinshu Univ, Sch Med, Dept Mol Oncol & Angiol, Res Ctr Aging & Adaptat, Matsumoto, Nagano 3908621, Japan
[4] Shinshu Univ, Sch Med, Dept Clin & Mol Genet, Matsumoto, Nagano 3908621, Japan
关键词
D O I
10.1172/JCI200113030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the kenetics of p15 methylation and expression during myeloid development. We treated human cord blood CD34(+) cells with either GM-CSF alone or in combination with stem cell factor and followed methylation at this locus using bisulfite genomic sequencing. CD34(+) cells were found to be either fully methylated or completely unmethylated at 27 CpG dinucleotide sites in exon 1 and at 18 CpG sites in the promoter region of the p15 gene. A time-course study showed that the percentage of the allelic methylation of p15 CpG island increased to approximately 50% to 60% until 7 days after cytokine stimulation, then decreased to less than 10% after 21 days. The methylation was also observed in bone marrow CD34(+) cells exposed to GM-CSF. p15 expression varied inversely with methylation. Expression was negligible or at low levels until 14 days, after which it increased substantially. The frequency of myeloid colony-forming cells in the progeny decreased and myeloid-specific markers increased in the later stages. Based on our observations on cells grown with GM-CSF and 5-aza-2'-deoxtcytidine, DNA methylation of the p15 promoter region CpG island appears to be associated with proliferation rather than differentiation of normal human myeloid progenitors.
引用
收藏
页码:1195 / 1204
页数:10
相关论文
共 27 条
[1]  
Aggerholm A, 1999, CANCER RES, V59, P436
[2]   p15INK4B CPG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing [J].
Cameron, EE ;
Baylin, SB ;
Herman, JG .
BLOOD, 1999, 94 (07) :2445-2451
[3]   Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells [J].
Drexler, HG .
LEUKEMIA, 1998, 12 (06) :845-859
[4]   Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE) [J].
Gonzalgo, ML ;
Jones, PA .
NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2529-2531
[5]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[6]  
Herman JG, 1996, CANCER RES, V56, P722
[7]  
Herman JG, 1997, CANCER RES, V57, P837
[8]   Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands [J].
Herman, JG ;
Graff, JR ;
Myohanen, S ;
Nelkin, BD ;
Baylin, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9821-9826
[9]   Megakaryocytes derived from CD34-positive cord blood cells produce interleukin-8 [J].
Higuchi, T ;
Koike, K ;
Sawai, N ;
Mwamtemi, HH ;
Takeuchi, K ;
Shiohara, M ;
Kikuchi, T ;
Yasui, K ;
Ito, S ;
Yamagami, O ;
Sasaki, Y ;
Okumura, N ;
Kato, T ;
Miyazaki, H ;
Ikeda, M ;
Yamada, M ;
Komiyama, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) :509-516
[10]  
Higuchi T, 1997, EXP HEMATOL, V25, P463